Survival of the Fittest: Time-To-Event Modeling of Crystallization of Amorphous Poorly Soluble Drugs
Open Access
- 1 June 2016
- journal article
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 105 (6) , 1858-1866
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Long-Term Amorphous Drug Stability Predictions Using Easily Calculated, Predicted, and Measured ParametersMolecular Pharmaceutics, 2015
- Amorphous Solid dispersions: a Robust Platform to Address Bioavailability ChallengesTherapeutic Delivery, 2015
- Classification of the Crystallization Behavior of Amorphous Active Pharmaceutical Ingredients in Aqueous EnvironmentsPharmaceutical Research, 2013
- Early drug development predictions of glass-forming ability and physical stability of drugsEuropean Journal of Pharmaceutical Sciences, 2013
- Solubility Advantage of Amorphous Pharmaceuticals, Part 3: Is Maximum Solubility Advantage Experimentally Attainable and Sustainable?Journal of Pharmaceutical Sciences, 2011
- Investigation of properties and recrystallisation behaviour of amorphous indomethacin samples prepared by different methodsInternational Journal of Pharmaceutics, 2011
- A Classification System to Assess the Crystallization Tendency of Organic Molecules from Undercooled MeltsJournal of Pharmaceutical Sciences, 2010
- Correlating thermodynamic and kinetic parameters with amorphous stabilityEuropean Journal of Pharmaceutical Sciences, 2009
- Role of Thermodynamic, Molecular, and Kinetic Factors in Crystallization from the Amorphous StateJournal of Pharmaceutical Sciences, 2008
- A Comparison of the Physical Stability of Amorphous Felodipine and Nifedipine SystemsPharmaceutical Research, 2006